Rockwall, TXNCT07125833Now EnrollingIRB Ready

Degenerative Joint Disease of Shoulder Clinical Trial in Rockwall, TX

Access cutting-edge degenerative joint disease of shoulder treatment through this clinical trial at a research site in Rockwall. Study-provided care at no cost to qualified participants.

Sponsored by North Texas Medical Research Institute, PLLC

Quick Self-Assessment

See if you qualify for this Rockwall location

Preparing your pre-screening questions…

Expert Care in Rockwall

Access degenerative joint disease of shoulder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related degenerative joint disease of shoulder treatment provided free

Apply for This Rockwall Location

Check if you qualify for this degenerative joint disease of shoulder clinical trial in Rockwall, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Rockwall

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Rockwall site if eligible
  4. 4Begin participation

About This Degenerative Joint Disease of Shoulder Study in Rockwall

The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).

Sponsor: North Texas Medical Research Institute, PLLC

Who Can Participate

Inclusion Criteria

Male patients or female who are not pregnant and do not plan on future pregnancy during trial participation
between 30-85 years of age
BMI less than or equal to 45
Currently setup for an elective primary reverse total shoulder arthroplasty due to primary osteoarthritis
Ability to provide informed consent to participate in the clinical trial
Ability to understand and communicate in English
Willingness to comply with all study procedures

Exclusion Criteria

poorly controlled comorbidities that would not allow surgical intervention such as poorly controlled diabetes (HbA1C \> 8.0) renal insufficiency (eGFR \<60) poorly controlled CV disease such as CHF that is NYHA class 3 and 4
inability to receive the intervention including contraindications:
Cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, Raynaud's disease, and open and/or infected wounds at or near the treatment site
patients with history of total joint infection ever or any infection in the last 6 months
ASA score \>3 and Outpatient Arthroplasty Risk Assessment (OARA; medical risk stratification scoring system to help determine day surgery vs inpatient)1 score \> 80.
previous cryoneurolysis of the suprascapular nerve-utilization of supplemental/holistic methods specifically for pain control (e.g. cannabidiol). This will be discontinued 30 days prior to RTSA and will not be used during the duration of study participation. This will be evaluated by the Principal Investigator and study team prior to consent.
significant anti-coagulation usage (other than aspirin) 7 days prior to treatment
CV surgery within the last 6 months
significant neurologic compromise (acquired or congenital/genetic) of the upper extremity to be operated on or underlying neurologic condition that would confound results in the opinion of the investigator such as a

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Rockwall?

Yes, this clinical trial (NCT07125833) has an active research site in Rockwall, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Degenerative Joint Disease of Shoulder Treatment Options in Rockwall, TX

If you're searching for degenerative joint disease of shoulder treatment options in Rockwall, TX, this clinical trial (NCT07125833) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Rockwall research site is actively enrolling participants for this clinical trial. You'll receive care from experienced degenerative joint disease of shoulder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all degenerative joint disease of shoulder clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Rockwall, TX

See all rheumatoid arthritis clinical trials recruiting in Rockwall — not just this study.

Browse Rheumatoid Arthritis Trials in Rockwall →

Ready to Join in Rockwall?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Rockwall, TX